Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall.

A Larsson, B Astedt

Immunoreactive plasminogen activators were studied in tissue sections using a peroxidase method and monospecific antibodies to tissue plasminogen activator produced by a melanoma. Tissue plasminogen activator reactivity was found in skin melanomas and in endothelial and smooth muscle cells of arteries and veins. Vessels of the umbilical cord showed higher reactivity than peripheral vessels. Only faint antiurokinase reactivity was found. By means of the fibrin slide technique, fibrinolytic activity could be shown in peripheral vessel walls but not in the umbilical cord, which suggests that immunoreactivity of tissue plasminogen activator bound to an inhibitor can also be demonstrated. This method may be a useful tool in further studies of tissue plasminogen activator in physiological as well as pathological processes.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Carroll, V. A., Nikitenko, L. L., Bicknell, R., Harris, A. L. (2005). Antiangiogenic Activity of a Domain Deletion Mutant of Tissue Plasminogen Activator Containing Kringle 2. Arterioscler. Thromb. Vasc. Bio. 25: 736-741 [Abstract] [Full Text]  
• Rosnoblet, C., Vischer, U. M., Gerard, R. D., Irminger, J.-C., Halban, P. A., Kruithof, E. K. O. (1999). Storage of Tissue-Type Plasminogen Activator in Weibel-Palade Bodies of Human Endothelial Cells. Arterioscler. Thromb. Vasc. Bio. 19: 1796-1803 [Abstract] [Full Text]  
• Kauhanen, P., Siren, V., Carpen, O., Vaheri, A., Lepantalo, M., Lassila, R. (1997). Plasminogen Activator Inhibitor-1 in Neointima of Vein Grafts : Its Role in Reduced Fibrinolytic Potential and Graft Failure. Circulation 96: 1783-1789 [Abstract] [Full Text]  
• Labarrere, C. A., Pitts, D., Nelson, D. R., Faulk, W. P. (1995). Vascular Tissue Plasminogen Activator and the Development of Coronary Artery Disease in Heart-Transplant Recipients. NEJM 333: 1111-1116 [Abstract] [Full Text]